Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

CASIRIVIMAB and IMDEVIMAB {REGEN-COV}: 101 …Regeneron Pharmaceuticals’ monoclonal antibodies: a rescue pharmacotherapy for COVID-19…

October 25, 2021

Aya Allam, M.D., Steven Lippmann, M.D. Besides all the pandemic talk these days, we hear lots about coronavirus treatment with monoclonal antibodies. There are many of them. What is the big deal? Casirivimab and imdevimab are two monoclonal antibodies synthesized by the pharmaceutical company Regeneron, brand-named REGEN-COV. These dual proteins are a monoclonal antibodies intervention […]

Clinical characteristics and psychiatric comorbidities in veterans with schizophrenia with or without suicidality

October 19, 2021

Leo Sher, M.D. Our research report, “Clinical features and psychiatric comorbidities in military veterans with schizophrenia with or without suicidality” is published in the November 2021 issue of the Journal of Psychiatric Research (1). There is a need to increase our understanding of what elevates suicide risk in veterans with schizophrenia as a first step […]

Treatment of suicide attempters with bipolar disorder: a randomized clinical trial

October 18, 2021

Leo Sher, M.D. Our research report, “Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior” was published in the October 2011 issue of the American Journal of Psychiatry (1). In our double-blind, randomized, parallel-group study, we tested the hypothesis that lithium offers bipolar […]

Changes in suicide mortality during the COVID-19 pandemic

October 13, 2021

Leo Sher, M.D. A research article, “Changes in suicide mortality of Hungary during the first year of the COVID-19 pandemic” has been published in Orvosi Hetilap, a Hungarian medical journal (1). The authors compared the observed number of suicides during the COVID-19 pandemic in March–December 2020 with the expected numbers which were calculated based on […]

The Nobel Prize in Physiology or Medicine 2021

October 12, 2021

Leo Sher, M.D. American scientists David Julius and Ardem Patapoutian were awarded the 2021 Nobel Prize in Physiology or Medicine for their discoveries of receptors for temperature and touch (1). The Nobel Committee states that “David Julius utilized capsaicin, a pungent compound from chili peppers that induces a burning sensation, to identify a sensor in […]

Cerebrospinal fluid monoamine metabolite levels and lethality of suicide attempts in patients with bipolar disorder: a prospective study

October 7, 2021

Leo Sher, M.D. Our research work, “A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder” was published 15 years ago in the October 2006 issue of Bipolar Disorders (1). We examined the relation between CSF 5-hydroxyindolacetic acid (5-HIAA), homovanillic acid (HVA), and […]

2021 National Veteran Suicide Prevention Annual Report

October 4, 2021

Leo Sher, M.D. The Office of Mental Health and Suicide Prevention of the U.S. Department of Veterans Affairs recently published the 2021 National Veteran Suicide Prevention Annual Report (1). This report provides information from 2001 through 2019, while recent prior reports included data from 2005 forward. Also, this report includes the most current data and […]

Ivermectin: 101

September 28, 2021

Gurpreet Singh Guliani, M.D., Steven Lippmann, M.D. We have been hearing a lot about ivermectin these days. You too? Well, ivermectin has long been established as a veterinary medication to treat animals with many different types of parasitic infections; useful there, it has been around for a while without fanfare. Ivermectin is also approved for […]

Coronavirus and Alzheimer’s disease – trust in FDA Vaccinations and Aducanumab

September 12, 2021

Aya Allam, M.D., Steven Lippmann, M.D. Now in our second year of a coronavirus pandemic, the Food and Drug Administration (FDA) is approving COVID-19 vaccines. They are well researched, proven safe, currently effective, and already utilized by millions of people. Trust in the FDA as a medical authority enhances their recommendations for getting immunized. Similarly, […]

Early response to light therapy and long-term antidepressant effects in patients with seasonal affective disorder

September 9, 2021

Leo Sher, M.D. Our research paper, “Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder” was published 20 years ago in the September 2001 issue of the Journal of Psychiatry and Neuroscience (1). The aim of the study was to determine if the antidepressant effect of 1 hour […]

«‹ 15 16 17 18›»

Editorials

  • The role of the h-index in academic medicine
  • A timeless commitment: Reflections on the Hippocratic Oath
  • Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  
  • Suicide medical malpractice: A conceptual perspective

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Blood alcohol concentration and suicide mortality in Finland
  • Suicide risk in older adults: clinical responsibilities and medico-legal considerations
  • Conceptualizing a combat veteran’s suicide death through the stress-diathesis model
  • No evidence of a causal link between glucagon-like peptide-1 receptor agonists and suicidal behavior

Latest News

  • FDA launches real-time clinical trial initiative
  • The 2025 ScholarGPS rankings of leading scholars in suicidology
  • Mental health support for healthcare professionals
  • The 2024 ScholarGPS ranking of scholars in the field of suicidology

Interviews with eminent psychiatrists

  • 2026 Interview with Professor Zoltan Rihmer
  • 2026 Interview with Doctor María Dolores Braquehais Conesa
  • 2026 Interview with Professor Shih-Ku Lin
  • Interview with Professor Jess G. Fiedorowicz

Ten Years Ago

  • Suicide malpractice
  • Testosterone levels and future suicide attempts in women with bipolar disorder
  • Bipolar disorder, testosterone administration, and homicide
  • The cosyntropin stimulation test in military veterans with or without posttraumatic stress disorder

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2025 AVCalc LLC. All rights reserved worldwide.